Figure 4.
In vivo distribution and migration of PbS QDs labeled ADSCs in a rat model of sciatic nerve injury. (A) Schematic illustration of the in vivo NIR-II imaging strategy. (B) Bright field photograph of the region of interest and NIR-II imaging of the experimental group (injected with PbS QDs labeled ADSCs) in a time course (0 d, 1 h, 1 d, 5 d, 7 d, 10 d, and 14 d post-injection). (C) Bright field photograph of the region of interest and NIR-II imaging of the control group (injected with pure PbS QDs) in a time course (0 d, 1 h, 1 d, 5 d, 7 d, 10 d, and 14 d post-injection). (D) Fluorescence area and (E) PL intensity of the proximal and distal sections of the sciatic nerve. (F) The ratio of PL intensity in distal/proximal nerve sections in the experimental group and the control group.
